Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

Discovery of our facilities by Minister Willy Borsus and AWEX members

Next post

Recommended for you

24-25 March 2026

Nextgen Biomed 2026

London, UK

Meet Eurogentec at "Nextgen Biomed 2026"

@ London, UK
📅March 24-25, 2026
📍London (UK) - Booth #61
...
Continue Reading
11-14 May 2026

TIDES USA 2026

Boston, MA, USA

Eurogentec at "TIDES USA 2026"

@ Boston, MA, USA
📅May 11-14, 2026
📍Boston (USA) - Booth #800...
Continue Reading
22-25 June 2026

BIO 2026

San Diego, CA, USA

Meet us at "BIO International Convention 20..

@ San Diego, CA, USA
📅June 22-25, 2026
📍San Diego, USA - Booth #5451...
Continue Reading